Literature DB >> 28725252

Individualized 3D scanning and printing for non-melanoma skin cancer brachytherapy: a financial study for its integration into clinical workflow.

Meritxell Arenas1, Sebastià Sabater2, Andreu Sintas3, Monica Arguís1, Víctor Hernández4, Miguel Árquez1, Iolanda López1, Àngeles Rovirosa5, Doménec Puig3.   

Abstract

PURPOSE: Skin cancer is the most common tumor in the population. There are different therapeutic modalities. Brachytherapy is one of the techniques used, in which it is necessary to build customized moulds for some patients. Currently, these moulds are made by hand using rudimentary techniques. We present a new procedure based on 3D printing and the analysis of the clinical workflow.
MATERIAL AND METHODS: Moulds can be made either by hand or by automated 3D printing. For making moulds by hand, a patient's alginate negative is created and, from that, the gypsum cast and customized moulds are made by hand from the patient's negative template. The new process is based on 3D printing. The first step is to take a 3D scan of the surface of the patient and then, 3D modelling software is used to obtain an accurate anatomical reconstruction of the treatment area. We present the clinical workflow using 3D scanning and printing technology, comparing its costs with the usual custom handmade mould protocol.
RESULTS: The time spent for the new process is 6.25 hours, in contrast to the time spent for the conventional process, which is 9.5 hours. We found a 34% reduction in time required to create a mould for brachytherapy treatment. The labor cost of the conventional process is 211.5 vs. 152.5 hours, so the reduction is 59 hours. There is also a 49.5% reduction in the financial costs, mostly due to lack of need of a computed tomography (CT) scan of the gypsum and the mould. 3D scanning and printing offers financial benefits and reduces the clinical workload.
CONCLUSIONS: As the present project demonstrates, through the application of 3D printing technologies, the costs and time spent during the process in the clinical workload in brachytherapy treatment are reduced. Overall, 3D printing is a promising technique for brachytherapy that might be well received in the community.

Entities:  

Keywords:  3D printing; brachytherapy; moulds; skin cancer

Year:  2017        PMID: 28725252      PMCID: PMC5509979          DOI: 10.5114/jcb.2017.68134

Source DB:  PubMed          Journal:  J Contemp Brachytherapy        ISSN: 2081-2841


Purpose

New radiotherapy techniques are emerging that will improve treatment planning and delivery. One of those is the use of 3D printing technology, which is being utilized more frequently in medicine more each year [1,2,3]. In radiotherapy, 3D printing has been introduced to create boluses [4,5,6,7,8,9], phantoms for quality assurance [10,11,12,13], compensator blocks [14], proton range compensators [15], and tools for brachytherapy [16,17,18,19,20,21,22]. Skin cancer is currently one of the most common tumors [23,24]. One radiotherapy technique used in treatment is high-dose-rate brachytherapy, which involves making individualized moulds [25]. A mould of such precise characteristics must be made perfectly adapted to the patient’s anatomy, which is expensive (especially in terms of personnel) and causes patient discomfort. Our study analyses the clinical workflow using 3D scanning and printing technology, and comparing its costs with the usual custom handmade mould protocol.

Material and methods

One of the most important aspects of treatment planning for skin cancer is defining the target volume. In brachytherapy, customized moulds are indicated in those cases where the tumors are located in irregular anatomical areas, and a perfect match between the mould and the skin is essential. Moulds can be made either by hand (Figure 1) or by automated 3D printing (Figure 2).
Fig. 1

Process of creating, by hand, a personalized mould for the treatment of a cutaneous cancer. 1, 2 – delimitation of the treatment zone, patient protection; 3, 4 – applying the plaster on wax for the negative mould of the treatment area; 5, 6 – drying and developing the treatment area; 7 – assembly of the multilayer application

Fig. 2

Process of creating, by 3D printing, a personalized mould for the treatment of a cutaneous cancer. 1 – 3D scan of the patient; 2, 3, 4 – model of the patient and delimitation of the treatment zone (lesion in the right nasal area); 5 – creation and placement of the markers for the catheters; 6 – creation of a surface and minimum depth in the model that will be printed; 7 – mould after printing

Process of creating, by hand, a personalized mould for the treatment of a cutaneous cancer. 1, 2 – delimitation of the treatment zone, patient protection; 3, 4 – applying the plaster on wax for the negative mould of the treatment area; 5, 6 – drying and developing the treatment area; 7 – assembly of the multilayer application Process of creating, by 3D printing, a personalized mould for the treatment of a cutaneous cancer. 1 – 3D scan of the patient; 2, 3, 4 – model of the patient and delimitation of the treatment zone (lesion in the right nasal area); 5 – creation and placement of the markers for the catheters; 6 – creation of a surface and minimum depth in the model that will be printed; 7 – mould after printing

Making moulds by hand

The patient’s alginate negative is created and, from that, the gypsum cast is also made. The gypsum takes about 24 hours to dry, and then the treatment area is defined. Customized moulds are made by hand from the patient’s negative template and different wax layers are added to place the catheter tubes between them (Figure 3A). Next, a computed tomography (CT) scan of the gypsum and the mould is taken to confirm the suitability of the mould. If everything is correct, another CT scan is taken with the mould located on the patient. Finally, the radiation oncologist delineates the target volume and organs at risk, and treatment planning is carried out.
Figure 3

A) Customized mould for treating skin cancer made by conventional process; B) 3D printed mould made with novel process

A) Customized mould for treating skin cancer made by conventional process; B) 3D printed mould made with novel process

The new process based on 3D printing

The use of a 3D surface scanner (Sense Scanner from 3D Systems (Rock Hill, SC, USA), 480 euros), a 3D printer (BCN3D Sigma, from BCN3D Technologies, Castelldefels, Barcelona, Spain, 2300 euros) and 3D modeling software (MeshMixer, Opensource) radically changes the process. The first step is to take a 3D scan of the surface of patient. The resultant image is an accurate anatomical reconstruction of the treatment area. Then, 3D modelling software is used to completely adapt the model to the particular anatomy of a patient, adding the required depth and marking cylindrical spaces for placing the catheters, which can be located accurately at least 5 mm above the skin and 1 cm from each other (Figure 3B), which is the configuration needed for the treatment. The final step is to take a CT scan of the 3D printed mould on the patient, thus avoiding the need for a CT scan of the gypsum and the mould. The area that we want to treat is delineated and the dosimetry is carried out, similar to the conventional procedure. Table 1 shows the times that were estimated from mean times obtained in typical clinical procedures. Labor costs were calculated taking into account the hourly cost of the radiation oncologist, physicist, and radiation therapist, according to hospital salary tables (radiation oncologist and physicist: 38 euros per hour; radiation therapist: 15 euros per hour).
Table 1

Summary of the workflow for the conventional process and the new proposal with time and costs requirements

Conventional processNovel process based on 3D printing
PhasesTime (hours)Waiting time (hours)Human cost (euros)Material cost (euros)PhasesTime (hours)Waiting time (hours)Human cost (euros)Material cost (euros)
1. Definition of target0.5 (RO)191. Definition of target0.5 (RO)19
2. Creation of the patient’s alginate negative1 (RT)1552. Patient 3D scan0.25 (RT)5
3. Creation of the gypsum from the patient’s negative0.5 (RT)247.533. 3D image preparation0.57.5
4. Definition of the area to treat in the gypsum0.5 (RO)19
5. Creation of the counter mould with wax0.5 (RT)7.55
6. Placement of catheter tubes0.5 (RT)7.5
7. Addition of extra wax layers to make the final mould0.5 (RT)7.554. 3D printing of the mould with guide tubes78*
8. CT of the gypsum and the mould0.5 (RT)247.5150
9. CT of the mould on the patient0.5 (RT)247.51505. CT of the mould on the patient0.5 (RT)247.5150
10. Treatment planning2 (RT)306. Treatment planning2 (RT)30
11. Planning approval1 (P)1 (RO)767. Planning approval1 (P)1 (RO)76
12. Treatment verification0.5 (RT)7.58. Treatment verification0.5 (RT)7.5
Total9.572211.5318Total6.2531152.5158

CT – computed tomography, RO – radiation oncologist, RT – radiation therapist, P – physicist

Considering maintenance and reliability costs

Summary of the workflow for the conventional process and the new proposal with time and costs requirements CT – computed tomography, RO – radiation oncologist, RT – radiation therapist, P – physicist Considering maintenance and reliability costs

Results

Table 1 shows the labor and material costs comparison between the two processes. The time spent on the new process is 6.25 hours, in contrast to the time spent on the conventional process, which is 9.5 hours, so we found a 34% reduction in the time taken to make the mould for brachytherapy treatment (not considering the time in which the mould is being printed, as it requires no human attention). The labor cost of the conventional process is 211.5 vs. 152.5 hours, therefore the reduction is 59 hours. There is also a 49.5% reduction in the financial costs, mostly due to no need of a CT scan of the gypsum and the mould. 3D printing technology would also greatly reduce the time spent creating brachytherapy moulds, with the waiting time reduced by 57% due to the gypsum taking 24 hours to dry. This will create huge benefits for the patients, as they would be able to start the dosimetry treatment sooner and reduce the time spent in the hospital by 45 minutes (2 hours for conventional vs. 1¼ hours for 3D printing). The new process also reduces the discomfort caused when creating the negative and the gypsum moulds, which are particularly uncomfortable steps in the conventional process. Table 2 shows the analysis of the cost of 3D printing a mould of a patient, printed at 90% infill and weighing 94 gram (thus requiring 7 hours working time). This is the typical configuration when printing a mould from a facial skin lesion patient. The 3D printer price includes the start-up cost, maintenance, and reliability costs. We have calculated costs based on 60 patients per year, therefore 7 hours per patient represents 2,520 hours of working time over a 6 year period, which can be estimated as a minimum working time for the printer. The initial investment needed to acquire this new 3D printing technology are around 480 euros for the scanner and 1,800-2,300 euros for the printer. The printer used in this study cost 2,300 euros, as it has a dual-extruder function; however, printers without this functionality, which cost less, around 1,800 euros, are capable of the same workflow. A cost reduction is therefore evident and would be even greater in centers with larger number of patients.
Table 2

Analysis of the cost of 3D printing a mould of a patient, printed at 90% infill and weighing 94 gram (taking 7 hours)

PhasesUnit costCost per hour (euros)Total cost (euros)
3D printer (considering workflow of 60 patients per year and over a period of 6 years)1,800-2,300 €0.71-0.914.97-6.37
PLA spool20.80 €/kg1.96
Disposables0.1
Electricity (240 Watts)0.16 €/kWh0.27
Repair cost (about 10% of purchase cost over the 6 years)180-230 €0.07-0.090.5-0.64
Software000
Subtotal7.8-9.34
Failed moulds (considering a 15% failure)1.17-1.4
Total8.97-10.74

Note: Printers costing as little as 1,800 € can offer the same reliability as the printer currently used in this study, which cost 2,300 €. The low-high figures in this example reflects the price difference.

Analysis of the cost of 3D printing a mould of a patient, printed at 90% infill and weighing 94 gram (taking 7 hours) Note: Printers costing as little as 1,800 € can offer the same reliability as the printer currently used in this study, which cost 2,300 €. The low-high figures in this example reflects the price difference.

Discussion

Radiation therapy is an effective treatment for skin cancer. Several techniques can be used, such as superficial X-rays, orthovoltage X-rays, megavoltage photons, electron beam irradiation, and brachytherapy. Radiotherapy is continuing to introduce new technologies into the workflow, like magnetic resonance imaging (MRI) [1], and devices that come from other fields of the science, like the surface scanners and 3D-printers. Skin cancer brachytherapy treatment can be carried out using interstitial or plesiotherapy techniques [26,27,28,29,30,31]. High-dose-rate electronic brachytherapy using surface applicators for the treatment of non-melanoma skin carcinoma is a relatively new technique [32,33]. Plesiotherapy can be delivered by fixed applicators for treating small tumors in flat areas or by customized moulds that adapt radiation doses to very uneven surfaces without the need to shield surrounding areas. We have presented a new process for creating moulds based on 3D printing, and a financial study for its integration into the clinical workflow. The mould that is created by 3D printing offers a reduction in time taken to make the mould and a reduction in material costs. In spite of the modest time saving, the new workflow gives the opportunity to measure the 3D surface of the patient, who can be in the general practitioner’s office or in satellite units belonging to the hospital network. We are currently actively working on this area [34]. The use of modelling software allows for a quicker and automated creation of radiotherapy complements. The costs have been calculated based on the fact that the Spanish regulations state that only materials for medical use must have a certificate. Surface scanner and 3D printers do not need any special certification. National variations in regulations might alter costs. Both maintenance, reliability, and electricity costs have been included in the printing price calculated, taking into account a flow of 60 patients per year, which is the current demand in our hospital. The proportional depreciation cost of the printer will be lower in those centers with a higher need, as will the cost of each printing job. For the calculations, a minimum operating period of six years and a failure rate of 15% were considered. Our goal is to maintain only 2 workflows in the Department for this type of patient. The first, addressing largely irregular areas or places with important aesthetic issues, like the face, will involve the 3D printing technique. The second, addressing flat area with lesser aesthetic importance, will continue with standard, re-usable, and cheaper moulds. The reason for this difference lies in the fact that the re-usable moulds have drawbacks like the creation of air pockets between curved skin surfaces and the moulds. Obviously, implementation and standardization of the 3D printing technique depends on the number of patients that might benefit in each radiation department. All tests have been carried out for small to medium-sized areas. However, the only limitation is the size of the printer. As long as the area is small enough to fit onto the printer platform (in our case is 21 × 30 × 21 cm), any size moulds can be printed. Moulds that are too big can be created in parts and assembled later. No minimum size is required, as long as it covers the affected area. Once obtained, the 3D model can be adapted, and a mould bigger than the affected area can be printed in order to comfortably fit the patient’s skin, regardless of the dimensions of the tumor. For example, for a nasal lesion, the printed mould can extend from between the eyebrows to the mouth in order to fit all the area properly. We suggest the new process will be well received among the brachytherapy community, patients, and professionals alike (radiation oncologists, physicists, radiation therapists). It is an alternative therapeutic technique that reduces workload and saves time, allowing patients to move into treatments much sooner. More complex moulds can be created by machine rather than by hand thus reducing the possibility of human error. 3D printing improves reproducibility of the mould, as well as its quality and durability, meaning better overall quality [35]. The consistency of the tube placement (1 cm apart and 5 mm from the skin) will provide dosimetric advantages. The position and number of catheters can be defined before the mould is actually constructed, based on the patient’s CT data. Thus, optimization plan might include the number and position of the catheters, which would provide dosimetrically superior treatment plans. However, we are currently at the preliminary stage, in which we are validating whether the method can be applied. Incorporation of the mould design in the optimization process is still in progress, and will be addressed in the future. The final step, not yet reached in our department, is to create a complete inverse planning from the skin surface scanning to the optimal tube placement and the final mould creation, according to the previous steps. These personalized approaches could be adapted to other radiotherapy fields such as breast cancer [36]. The discomfort caused by the creation of the patients’ negative might be subjective and be interpreted differently, but we think the proposed process, which only requires the use of a contactless surface scanner on the patient, is much less intrusive and faster than the conventional process. Although no formal tests were given to patients, they reported discomfort, especially when nose and eyes had to be included in the gypsum working area. The new process will cause less discomfort to the patient.

Conclusions

3D printing is a promising technique for brachytherapy. It offers financial advantages, a reduction in the clinical workload, and less discomfort to patients. However, before being implemented into clinical practice, future work is needed to validate dosimetry and to characterize the printing material.
  36 in total

1.  3D printing based on imaging data: review of medical applications.

Authors:  F Rengier; A Mehndiratta; H von Tengg-Kobligk; C M Zechmann; R Unterhinninghofen; H-U Kauczor; F L Giesel
Journal:  Int J Comput Assist Radiol Surg       Date:  2010-05-15       Impact factor: 2.924

2.  Technical Note: Characterization of custom 3D printed multimodality imaging phantoms.

Authors:  Matthew F Bieniosek; Brian J Lee; Craig S Levin
Journal:  Med Phys       Date:  2015-10       Impact factor: 4.071

3.  Do breast cups improve breast cancer dosimetry? A comparative study for patients with large or pendulous breasts.

Authors:  Meritxell Arenas; Víctor Hernández; Blanca Farrús; Katrin Müller; Marina Gascón; Alida Pardo; Roberto Berenguer; Sebastia Sabater
Journal:  Acta Oncol       Date:  2014-03-21       Impact factor: 4.089

4.  Decentralisation of radiation therapy. Is it possible and beneficial to patients? Experience of the first 5 years of a satellite radiotherapy unit in the province of Tarragona, Spain.

Authors:  Meritxell Arenas; David Gomez; Sebastià Sabater; Angeles Rovirosa; Albert Biete; Jordi Colomer
Journal:  Rep Pract Oncol Radiother       Date:  2014-11-08

5.  3D-printed applicators for high dose rate brachytherapy: Dosimetric assessment at different infill percentage.

Authors:  Rosalinda Ricotti; Andrea Vavassori; Alessia Bazani; Delia Ciardo; Floriana Pansini; Ruggero Spoto; Vittorio Sammarco; Federica Cattani; Guido Baroni; Roberto Orecchia; Barbara Alicja Jereczek-Fossa
Journal:  Phys Med       Date:  2016-09-01       Impact factor: 2.685

Review 6.  Non-melanoma skin cancer treated with high-dose-rate brachytherapy: a review of literature.

Authors:  Durim Delishaj; Agata Rembielak; Bruno Manfredi; Stefano Ursino; Francesco Pasqualetti; Concetta Laliscia; Francesca Orlandi; Riccardo Morganti; Maria Grazia Fabrini; Fabiola Paiar
Journal:  J Contemp Brachytherapy       Date:  2016-12-02

7.  Potential of 3D printing technologies for fabrication of electron bolus and proton compensators.

Authors:  Wei Zou; Ted Fisher; Miao Zhang; Leonard Kim; Ting Chen; Venkat Narra; Beth Swann; Rachana Singh; Richard Siderit; Lingshu Yin; Boon-Keng Kevin Teo; Michael McKenna; James McDonough; Yue J Ning
Journal:  J Appl Clin Med Phys       Date:  2015-05-08       Impact factor: 2.102

8.  Trends in incidence of skin basal cell carcinoma. Additional evidence from a UK primary care database study.

Authors:  Fiona Bath-Hextall; Jo Leonardi-Bee; Chris Smith; Andy Meal; Richard Hubbard
Journal:  Int J Cancer       Date:  2007-11-01       Impact factor: 7.396

9.  Highly conformal CT based surface mould brachytherapy for non-melanoma skin cancers of earlobe and nose.

Authors:  Łukasz Kuncman; Sławomir Kozłowski; Andrzej Pietraszek; Malwina Pietrzykowska-Kuncman; Justyna Danielska; Janusz Sobotkowski; Jolanta Łuniewska-Bury; Jacek Fijuth
Journal:  J Contemp Brachytherapy       Date:  2016-07-01

10.  Design and production of 3D printed bolus for electron radiation therapy.

Authors:  Shiqin Su; Kathryn Moran; James L Robar
Journal:  J Appl Clin Med Phys       Date:  2014-07-08       Impact factor: 2.102

View more
  11 in total

1.  Evaluation of camera settings for photogrammetric reconstruction of humanoid phantoms for EBRT bolus and HDR surface brachytherapy applications.

Authors:  Corey A Bridger; Michael J J Douglass; Paul D Reich; Alexandre M Caraça Santos
Journal:  Phys Eng Sci Med       Date:  2021-04-12

2.  Recommendations of the Spanish brachytherapy group (GEB) of Spanish Society of Radiation Oncology (SEOR) and the Spanish Society of Medical Physics (SEFM) for high-dose rate (HDR) non melanoma skin cancer brachytherapy.

Authors:  S Rodríguez; M Arenas; C Gutierrez; J Richart; J Perez-Calatayud; F Celada; M Santos; A Rovirosa
Journal:  Clin Transl Oncol       Date:  2017-08-14       Impact factor: 3.405

Review 3.  3D Printed Personalized Medicine for Cancer: Applications for Betterment of Diagnosis, Prognosis and Treatment.

Authors:  Harshada Bhuskute; Pravin Shende; Bala Prabhakar
Journal:  AAPS PharmSciTech       Date:  2021-12-01       Impact factor: 3.246

Review 4.  Vaginal cuff brachytherapy in endometrial cancer - a technically easy treatment?

Authors:  Sebastià Sabater; Ignacio Andres; Veronica Lopez-Honrubia; Roberto Berenguer; Marimar Sevillano; Esther Jimenez-Jimenez; Angeles Rovirosa; Meritxell Arenas
Journal:  Cancer Manag Res       Date:  2017-08-09       Impact factor: 3.989

5.  Inversely designed, 3D-printed personalized template-guided interstitial brachytherapy for vaginal tumors.

Authors:  Shuhei Sekii; Kayoko Tsujino; Kengo Kosaka; Satoshi Yamaguchi; Hikaru Kubota; Yoko Matsumoto; Yosuke Ota; Ryohei Sasaki; Toshinori Soejima
Journal:  J Contemp Brachytherapy       Date:  2018-10-09

6.  Three-dimensional printing in radiation oncology: A systematic review of the literature.

Authors:  Michael K Rooney; David M Rosenberg; Steve Braunstein; Adam Cunha; Antonio L Damato; Eric Ehler; Todd Pawlicki; James Robar; Ken Tatebe; Daniel W Golden
Journal:  J Appl Clin Med Phys       Date:  2020-05-27       Impact factor: 2.102

7.  3D Printing of Abdominal Immobilization Masks for Therapeutics: Dosimetric, Mechanical and Financial Analysis.

Authors:  Jessica Duarte; Maria Amélia Ramos Loja; Ricardo Portal; Lina Vieira
Journal:  Bioengineering (Basel)       Date:  2022-01-29

8.  SKIN-COBRA (Consortium for Brachytherapy data Analysis) ontology: The first step towards interdisciplinary standardized data collection for personalized oncology in skin cancer.

Authors:  Valentina Lancellotta; Josè Luis Guinot; Bruno Fionda; Agata Rembielak; Alessandro Di Stefani; Stefano Gentileschi; Francesco Federico; Ernesto Rossi; Benjamin Guix; Artur Jan Chyrek; Arenas Meritxell; Silvia Rodriguez Villalba; Giuseppe Ferdinando Colloca; Nicola Dinapoli; Carlotta Masciocchi; Jacopo Lenkowicz; Nicola Dino Capocchiano; Andrea Damiani; Vincenzo Valentini; Gyorgy Kovács; Luca Tagliaferri
Journal:  J Contemp Brachytherapy       Date:  2020-04-30

9.  Comparison of 3D printed nose bolus to traditional wax bolus for cost-effectiveness, volumetric accuracy and dosimetric effect.

Authors:  Christine Albantow; Catriona Hargrave; Amy Brown; Christopher Halsall
Journal:  J Med Radiat Sci       Date:  2020-02-03

Review 10.  The Role of 3D Printing in Planning Complex Medical Procedures and Training of Medical Professionals-Cross-Sectional Multispecialty Review.

Authors:  Jarosław Meyer-Szary; Marlon Souza Luis; Szymon Mikulski; Agastya Patel; Finn Schulz; Dmitry Tretiakow; Justyna Fercho; Kinga Jaguszewska; Mikołaj Frankiewicz; Ewa Pawłowska; Radosław Targoński; Łukasz Szarpak; Katarzyna Dądela; Robert Sabiniewicz; Joanna Kwiatkowska
Journal:  Int J Environ Res Public Health       Date:  2022-03-11       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.